Caesarean section and risk of type 1 diabetes

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • TEDDY Study Group - (Autor:in)
  • Tarini Singh - , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (Autor:in)
  • Andreas Weiss - , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (Autor:in)
  • Kendra Vehik - , University of South Florida (Autor:in)
  • Jeffrey Krischer - , University of South Florida (Autor:in)
  • Marian Rewers - , University of Colorado Denver (Autor:in)
  • Jorma Toppari - , University of Turku (Autor:in)
  • Åke Lernmark - , Lund University (Autor:in)
  • William Hagopian - , Pacific Northwest Diabetes Research Institute (Autor:in)
  • Beena Akolkar - , National Institutes of Health (NIH) (Autor:in)
  • Ezio Bonifacio - , Professur für Präklinische Stammzelltherapie und Diabetes, Deutsches Zentrum für Diabetesforschung - Paul Langerhans Institut Dresden (Partner: HMGU), Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (Autor:in)
  • Anette G. Ziegler - , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt, Technische Universität München (Autor:in)
  • Christiane Winkler - , Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (Autor:in)

Abstract

Aims/hypothesis: Delivery by Caesarean section continues to rise globally and has been associated with the risk of developing type 1 diabetes and the rate of progression from pre-symptomatic stage 1 or 2 type 1 diabetes to symptomatic stage 3 disease. The aim of this study was to examine the association between Caesarean delivery and progression to stage 3 type 1 diabetes in children with pre-symptomatic early-stage type 1 diabetes. Methods: Caesarean section was examined in 8135 children from the TEDDY study who had an increased genetic risk for type 1 diabetes and were followed from birth for the development of islet autoantibodies and type 1 diabetes. Results: The likelihood of delivery by Caesarean section was higher in children born to mothers with type 1 diabetes (adjusted OR 4.61, 95% CI 3.60, 5.90, p<0.0001), in non-singleton births (adjusted OR 4.35, 95% CI 3.21, 5.88, p<0.0001), in premature births (adjusted OR 1.91, 95% CI 1.53, 2.39, p<0.0001), in children born in the USA (adjusted OR 2.71, 95% CI 2.43, 3.02, p<0.0001) and in children born to older mothers (age group >28–33 years: adjusted OR 1.19, 95% CI 1.04, 1.35, p=0.01; age group >33 years: adjusted OR 1.80, 95% CI 1.58, 2.06, p<0.0001). Caesarean section was not associated with an increased risk of developing pre-symptomatic early-stage type 1 diabetes (risk by age 10 years 5.7% [95% CI 4.6%, 6.7%] for Caesarean delivery vs 6.6% [95% CI 6.0%, 7.3%] for vaginal delivery, p=0.07). Delivery by Caesarean section was associated with a modestly increased rate of progression to stage 3 type 1 diabetes in children who had developed multiple islet autoantibody-positive pre-symptomatic early-stage type 1 diabetes (adjusted HR 1.36, 95% CI 1.03, 1.79, p=0.02). No interaction was observed between Caesarean section and non-HLA SNPs conferring susceptibility for type 1 diabetes. Conclusions/interpretation: Caesarean section increased the rate of progression to stage 3 type 1 diabetes in children with pre-symptomatic early-stage type 1 diabetes. Data availability: Data from the TEDDY study (https://doi.org/10.58020/y3jk-x087) reported here will be made available for request at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Central Repository (NIDDK-CR) Resources for Research (R4R) (https://repository.niddk.nih.gov/).

Details

OriginalspracheEnglisch
Seiten (von - bis)1582-1587
Seitenumfang6
FachzeitschriftDiabetologia
Jahrgang67
Ausgabenummer8
PublikationsstatusVeröffentlicht - Aug. 2024
Peer-Review-StatusJa

Externe IDs

PubMed 38819466
ORCID /0000-0002-8704-4713/work/171553160

Schlagworte

Ziele für nachhaltige Entwicklung

Schlagwörter

  • Caesarean section, Progression, Type 1 diabetes, Type 1 diabetes susceptibility genes